Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy

Pharm Res. 1997 Feb;14(2):241-5. doi: 10.1023/a:1012069231506.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Intravesical
  • Antineoplastic Agents, Alkylating / pharmacology*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Transitional Cell / pathology
  • Cell Survival / drug effects
  • Mitomycin / pharmacology
  • Mitomycins*
  • Tumor Cells, Cultured / drug effects
  • Urinary Bladder Neoplasms / pathology*

Substances

  • Antineoplastic Agents, Alkylating
  • Mitomycins
  • Mitomycin
  • N-7-(2-(nitrophenyldithio)ethyl)mitomycin C